Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells

Bioconjugate Chemistry

Volumn 12, Issue 6, 2001, Pages 890-899

  David, A ^a   Kopeckova P ^b   Rubinstein, A ^a   Kopecek J ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; FLUORESCENCE MICROSCOPY;

BIORECOGNITION; CELL-BE; CELL/B.E; CELL/BE; GALACTOSE RESIDUES; GLYCOSYLATED; HUMAN HEPATOCARCINOMA; METHACRYLAMIDES; SIDE-CHAINS; SYNTHESISED;

SUGARS;

EID: 0035206993     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc010026v     Document Type: Article

References (56)

1. Receptor mediated glycotargeting
2. Drug delivery systems using carbohydrate recognition
3. Endogenous lectins and drug targeting
4. Lectins as cell recognition molecules
5. An endogenous carbohydrate-binding agglutinin of BHK cells. Purification, specificity and interaction with normal and ricin-resistant cell lines
6. Membrane lectins
7. Studies on the role of glycosyltransferases in the hepatic binding of asialoglycoproteins
8. Uptake and transport of mannosylated ligands by macrophages. Studies on ATP-dependent receptor - Ligand dissociation
9. Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting
10. Carbohydrate-specific receptors of the liver
11. Preparation and some biochemical properties of neoglycoproteins produced by reductive amination of thioglycosides containing an omega-aldehydoaglycon
12. Biochemistry of carbohydrate-protein interactions
13. Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line
14. Recycling of the asialoglycoprotein receptor and effect of lysosomotropic amines in hepatoma cells
15. Soluble polymers for lectin-mediated drug targeting
16. Syntheses and some applications of chemically defined multivalent glycoconjugates
17. Polyacrylamides bearing pendent α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: The strong inhibition reflects enhanced binding through cooperative polyvalent interactions
18. Blue-prints, synthesis and applications of glycopolymers
19. Tailor-made glycopolymer synthesis
20. Preparation of glycoprotein models: Pendant-type oligosaccharide polymers
21. Use of glycosylamines in preparation of oligosaccharide polyacrylamide copolymers
22. Glycosylated poly(L-lysine) as a hepatotropic carrier of 9-β-D-arabinofuranosyladenine 5'-monophosphate
23. Fate of N-(2-hydroxypropyl) methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats
24. Biorecognition of sugar containing N-(2-hydroxypropyl)-methacrylamide copolymers by immobilized lectin
25. New strategy in glycopolymer syntheses. Preparation of antigenic water-soluble poly(acrylamide-co-p-acrylamidophenyl β-lactoside)
26. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators
27. Polymer conjugates with anticancer activity
28. Clinical trial of PK1 (HPMA copolymer doxorubicin)
29. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
30. Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues
31. Pharmacokinetics of a polymeric drug carrier targeted to the hepatocyte galactose receptor
32. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action
33. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of Adriamycin conjugates against mouse leukemia L1210 in vivo
34. Intraperitoneal and subcutaneous retention of a soluble polymeric drug carrier bearing galactose
35. Structure and energetics of protein-carbohydrate complexes
36. Biological roles of oligosaccharides: All of the theories are correct
37. Enhanced biochemical affinity of multivalent neoglycoconjugates
38. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
39. Strength in numbers: Nonnatural polyvalent carbhydrate derivatives
40. Carbohydrate recognition systems: Functional triads in cell-cell interactions
41. Binding of synthetic oligosaccharide to the hepatic Gal/GalNAc lectin
42. The differences in structural specificity for recognition and binding between asialoglycoprotein receptors of liver and macrophages
43. A simplified, one-pot preparation of acetobromosugars from reducing sugars
44. Relations between rotatory power and structure in the sugar group. X. The chloro-, bromo- and iodo-acetyl derivatives of lactose
45. Monosaccharides
46. Poly[N-(2-hydroxypropyl) methacrylamide] I. Radical polymerization and copolymerization
47. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
48. N-(2-hydroxypropyl)methacrylamide copolymers containing pendant saccharide moieties: Synthesis and bioadhesives properties
49. Synthesis and some cluster glycosides suitable for attachment to proteins and solid matrixes
50. Synthesis of nonionic glycosidic surfactants derived from Tris(hydroxymethyl) aminomethane. Preliminary assessment
51. Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl) methacrylamide copolymers following intravenous administration in the rat
52. Structural specificity and polyvalent carbohydrate recognition by the Entamoeba histolytica and rat hepatic N-acetylgalactosamine/galactose lectins
53. 2+-dependent carbohydrate-recognition domains in animal proteins
54. Pharmacokinetics of a polymeric drug carrier targeted to the hepatocyte galactose receptor
55. Fate of galactosylated dextrans after in vivo administration